Growth inhibition of mesenchymal stem cells by aspirin: Involvement of the wnt/β-catenin signal pathway

Clinical and Experimental Pharmacology and Physiology

Volumn 33, Issue 8, 2006, Pages 696-701

  Wang, Yiner ^a   Chen, Xi ^a   Zhu, Weiquan ^a   Zhang, Hao ^a   Hu, Shengshou ^a   Cong, Xiangfeng ^a,b  

^a FUWAI HOSPITAL   (China)

^b Cardiovascular Institute   (China)

Author keywords

Aspirin; Mesenchymal stem cells; wnt catenin

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ACETYLSALICYLIC ACID; BETA CATENIN; CYCLIN D1; DNA; THYMIDINE; TRYPAN BLUE; WNT PROTEIN;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; DOWN REGULATION; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; GROWTH INHIBITION; IN VITRO STUDY; INHIBITION KINETICS; MESENCHYMAL STEM CELL; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BETA CATENIN; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN D1; DOSE-RESPONSE RELATIONSHIP, DRUG; MESENCHYMAL STEM CELLS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 33745952028     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2006.04432.x     Document Type: Article

References (48)

1. Mangi AA, Noiseux N, Kong O et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat. Med. 2003; 9: 1195-201.
2. Weisel RD, Fazel S, Fedak PW, Li RK. Cardiac restoration by cell transplantation. Int. J. Cardiol. 2004; 95 (Suppl. 1): S5-7.
3. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-7.
4. Jiang Y, Jahagirdar BN, Reinhardt RL et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41-9.
5. Makino S, Fukuda K, Miyoshi S et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 1999; 103: 697-705.
6. Silva GV, Litovsky S, Assad JA et al. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 2005; 111: 150-6.
7. Geng YJ. Molecular mechanisms for cardiovascular stem cell apoptosis and growth in the hearts with atherosclerotic coronary disease and ischemic heart failure. Ann. N. Y. Acad. Sci. 2003; 1010: 687-97.
8. Zhu W, Chen J, Cong X, Hu S, Chen X. Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells. Stem Cells 2006; 24: 416-25.
9. Awtry EH, Loscalzo J. Aspirin. Circulation 2000; 101: 1206-18.
10. Hung J. Aspirin for cardiovascular disease prevention. Med. J. Aust. 2003; 179: 147-52.
11. Sanmuganathan PS, Ghahramani P, Jackson PR, Wallis EJ, Ramsay LE. Aspirin for primary prevention of coronary heart disease: Safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials. Heart 2001; 85: 265-71.
12. Bernhardt J, Rogalla K, Luscher TF, Buhler FR, Resink TJ. Acetylsalicylic acid, at high concentrations, inhibits vascular smooth muscle cell proliferation. J. Cardiovasc. Pharmacol. 1993; 21: 973-6.
13. Pearce HR, Kalia N, Bardhan KD, Brown NJ. Effects of aspirin and indomethacin on endothelial cell proliferation in vitro. J. Gastroenterol. Hepatol. 2003; 18: 1180-7.
14. Langman MJ, Cheng KK, Gilman EA, Lancashire RJ. Effect of anti-inflammatory drugs on overall risk of common cancer: Case-control study in general practice research database. BMJ 2000; 320: 1642-6.
15. Patrignani P. Nonsteroidal anti-inflammatory drugs, COX-2 and colorectal cancer. Toxicol. Lett. 2000; 112-113: 493-8.
16. Coogan PF, Rosenberg L, Palmer JR et al. Nonsteroidal anti-inflammatory drugs and risk of digestive cancers at sites other than the large bowel. Cancer Epidemiol. Biomarkers Prev. 2000; 9: 119-23.
17. Gao J, Niwa K, Sun W et al. Non-steroidal anti-inflammatory drugs inhibit cellular proliferation and upregulate cyclooxygenase-2 protein expression in endometrial cancer cells. Cancer Sci. 2004; 95: 901-7.
18. Smalley WE, DuBois RN. Colorectal cancer and nonsteroidal anti-inflammatory drugs. Adv. Pharmacol. 1997; 39: 1-20.
19. Stockbrugger RW. Nonsteroidal anti-inflammatory drugs (NSAIDs) in the prevention of colorectal cancer. Eur. J. Cancer Prev. 1999; 8 (Suppl. 1): S21-5.
20. Gerrah R, Elami A, Stamler A, Smirnov A, Stoeger Z. Preoperative aspirin administration improves oxygenation in patients undergoing coronary artery bypass grafting. Chest 2005; 127: 1622-6.
21. Lecomte M, Laneuville O, Ji C, DeWitt DL, Smith WL. Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin. J. Biol. Chem. 1994; 269: 13 207-15.
22. Roth GJ, Majerus PW. The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein. J. Clin. Invest. 1975; 56: 624-32.
23. Kopp E, Ghosh S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 1994; 265: 956-9.
24. Stark LA, Din FV, Zwacka RM, Dunlop MG. Aspirin-induced activation of the NF-kappaB signaling pathway: A novel mechanism for aspirin-mediated apoptosis in colon cancer cells. FASEB J. 2001; 15: 1273-5.
25. Abramson S, Korchak H, Ludewig R et al. Modes of action of aspirin-like drugs. Proc. Natl Acad. Sci. USA 1985; 82: 7227-31.
26. Abramson SB, Leszczynska-Piziak J, Haines K, Reibman J. Non-steroidal anti-inflammatory drugs: Effects on a GTP binding protein within the neutrophil plasma membrane. Biochem. Pharmacol. 1991; 41: 1567-73.
27. Goel A, Chang DK, Ricciardiello L, Gasche C, Boland CR. A novel mechanism for aspirin-mediated growth inhibition of human colon cancer cells. Clin. Cancer Res. 2003; 9: 383-90.
28. Etheridge SL, Spencer GJ, Heath DJ, Genever PG. Expression profiling and functional analysis of wnt signaling mechanisms in mesenchymal stem cells. Stem Cells 2004; 22: 849-60.
29. Boland GM, Perkins G, Hall DJ, Tuan RS. Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J. Cell Biochem. 2004; 93: 1210-30.
30. Fridenshtein A, Petrakova KV, Kuralesova AI, Frolova GI. [Precursor cells for osteogenic and hemopoietic tissues. Analysis of heterotopic transplants of bone marrow]. Tsitologiia 1968; 10: 557-67 (in Russian).
31. Bruder SP, Jaiswal N, Haynesworth SE. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J. Cell Biochem. 1997; 64: 278-94.
32. Caplan AI. Mesenchymal stem cells. J. Orthop. Res. 1991; 9: 641-50.
33. Masferrer JL, Needleman P. Anti-inflammatories for cardiovascular disease. Proc. Natl Acad. Sci. USA 2000; 97: 12 400-1.
34. Weissberg PL, Qasim A. Stem cell therapy for myocardial repair. Heart 2005; 91: 696-702.
35. Schreinemachers DM, Everson RB. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 1994; 5: 138-46.
36. Hida T, Leyton J, Makheja AN et al. Non-small cell lung cancer cycloxygenase activity and proliferation are inhibited by non-steroidal antiinflammatory drugs. Anticancer Res. 1998; 18: 775-82.
37. Rao KV, Detrisac CJ, Steele VE, Hawk ET, Kelloff GJ, McCormick DL. Differential activity of aspirin, ketoprofen and sulindac as cancer chemopreventive agents in the mouse urinary bladder. Carcinogenesis 1996; 17: 1435-8.
38. Brown JD, Moon RT. Wnt signaling: Why is everything so negative? Curr. Opin. Cell Biol. 1998; 10: 182-7.
39. Dihlmann S, Klein S, Doeberitz Mv MK. Reduction of beta-catenin/ T-cell transcription factor signaling by aspirin and indomethacin is caused by an increased stabilization of phosphorylated beta-catenin. Mol. Cancer Ther. 2003; 2: 509-16.
40. Dihlmann S, Siermann A, von Knebel Doeberitz M. The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/ TCF-4 signaling. Oncogene 2001; 20: 645-53.
41. Marx J. Cancer research. Mutant stem cells may seed cancer. Science 2003; 301: 1308-10.
42. Normile D. Cell proliferation. Common control for cancer, stem cells. Science 2002; 298: 1869.
43. Valk-Lingbeek ME, Bruggeman SW, van Lohuizen M. Stem cells and cancer: The polycomb connection. Cell 2004; 118: 409-18.
44. Shtutman M, Zhurinsky J, Simcha I et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc. Natl Acad. Sci. USA 1999; 96: 5522-7.
45. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999; 398: 422-6.
46. Shiff SJ, Koutsos MI, Qiao L, Rigas B. Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells. Effects on cell cycle and apoptosis. Exp. Cell Res. 1996; 222: 179-88.
47. Elder DJ, Hague A, Hicks DJ, Paraskeva C. Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: Enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma relative to adenoma cell lines. Cancer Res. 1996; 56: 2273-6.
48. Redondo S, Santos-Gallego CG, Ganado P et al. Acetylsalicylic acid inhibits cell proliferation by involving transforming growth factor-beta. Circulation 2003; 107: 626-9.